Can you predict if SOL will hit $350 as ETF approvals near?

**Solana (SOL) is unlikely to reach $350 as ETF approvals near.** Here's why: 1. **Current Price and Market Sentiment**: Solana's current price is trading below the $350 mark, and recent sentiment indicators suggest a positive outlook with a sentiment score of 80 out of 100. However, this score is slightly down from its 30-day moving average, indicating a potential pause in the bullish trend. ETFs with Approvals Deciding Date is Next 30 Days |code|stock code|stock name|Last Price|Last Change|Drug Name|Indication|FDA Approval Status|FDA Review Date|market_code| |---|---|---|---|---|---|---|---|---|---| |CAPR|CAPR.O|Capricor|9.07|12.391574|Deramiocel (CAP-1002)|Duchenne muscular dystrophy|Pending|20250831|186| |BIIB|BIIB.O|Biogen|130.67|2.285714|Leqembi (Lecanemab) SC formulation|Alzheimer's disease|Pending|20250831|185| |IONS|IONS.O|Ionis Pharmaceuticals|41.64|1.437272|Donidalorsen (IONIS-PKK-LRx)|Hereditary angioedema|Pending|20250821|185| |REGN|REGN.O|Regeneron|563|0.5716330000000001|EYLEA HD(aflibercept) Injection|Macular edema following retinal vein occlusion|Pending|20250819|185| |INSM|INSM.O|Insmed|109.55|0.22872800000000001|Brensocatib|Non-Cystic Fibrosis Bronchiectasis|Pending|20250812|185| |TNXP|TNXP.O|Tonix|46.49|-0.9164540000000001|TNX-102 SL (Tonmya)|Fibromyalgia|Pending|20250815|186| |AXGN|AXGN.O|Axogen|13.9|-1.208244|Avance Nerve Graft|Nerve discontinuities|Pending|20250905|186| |AGIO|AGIO.O|Agios|35.76|-3.507825|PYRUKYND (Mitapivat)|Thalassemia|Pending|20250907|185| |PGEN|PGEN.O|Precigen|1.78|-5.319149|PRGN-2012 AdenoVerse(zopapogene imadenovec)|Recurrent respiratory papillomatosis, Cancer|Pending|20250827|185| |PTCT|PTCT.O|Ptc Therapeutics|45.38|-9.888800999999999|Vatiquinone (PTC743)|Friedreich’s Ataxia|Pending|20250819|185| 2. **Recent Performance and Investor Interest**: Despite positive sentiment, recent trading activity shows a 8.74% drop in on-chain activity, which highlights short-term hesitancy among investors. This could indicate a lack of immediate buying interest, which might prevent SOL from reaching the $350 mark. 3. **Technical Indicators and Potential Ceiling**: Technical analysis suggests that SOL is facing a potential ceiling at the $188 resistance level, with mixed signals from key technical indicators. This suggests that even with ETF approvals, SOL might not have sufficient momentum to surpass $350. 4. **Market Capitalization and Institutional Interest**: Solana has recently crossed a $100 billion market cap mark, indicating strong resilience and growth potential. However, institutional interest and partnerships are crucial for price movements. The lack of immediate buying interest from institutions could limit SOL's upward potential. 5. **Crypto Market Dynamics**: In the crypto market, sentiment can shift rapidly. While SOL has strong fundamentals and potential for long-term growth, the current technical indicators and market participation suggest a more conservative outlook. In conclusion, while Solana has a positive outlook and strong growth potential, the current price, market sentiment, and technical indicators suggest that SOL is unlikely to hit $350 as ETF approvals near. Investors should remain cautious and consider these factors when assessing SOL's future performance.